Mandate

Vinge has advised Randviken Fastigheter AB in connection with the acquisition and acquisition financing of real properties for a total agreed property value of approximately SEK 2.8 billion.

January 03, 2022 Real Estate and Construction

Vinge has advised Randviken Fastigheter AB (publ) in connection with the acquisition and acquisition financing of real properties for a total agreed property value of approximately SEK 2.8 billion. The acquisition was financed, inter alia, with bank facilities in an approximate amount of SEK 2.3 billion and was completed in December 2021.

The acquired properties are mainly located in Stockholm, Västerås and Malmö and the primary use is warehouse/light industrial, healthcare, school and office. The acquisition also includes a new construction project for office premises.

A significant part of the total loan amount is acquisition loans and the majority of the acquisition loans are senior loans and a smaller part is a bridge loan with a shorter maturity. The bank financing also includes a capex loan which will partly finance the completion of the new construction project.

Vinge’s team included Niclas Winnberg and Kristoffer Larson (Real Estate), as well as Fabian Ekeblad, Arvid Weimers and Elin Samara (Banking and Finance).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025